1. Automated measurement of transplantable solid tumors using digital electronic calipers interfaced to a microcomputer

   • John F. Worzalla
   • Jesse R. Bewley
   • Gerald B. Grindey

   Preclinical Studies Pages: 241 - 251

2. Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice

   • Patricia Mucci-LoRusso
   • Lisa Polin
   • Thomas H. Corbett

   Preclinical Studies Pages: 253 - 261

3. Combination of flavone acetic acid (FAA) with adriamycin, cis-platinum and difluoromethylornithine (DFMO) in vitro against human colon cancer cells

   • Sarabjit S. Neelam
   • Alvise Bernabei
   • Gordon D. Luk

   Preclinical Studies Pages: 263 - 268

4. Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule

   • Daniel R. Budman
   • Willi Kreis
   • Vincent Vinciguerra

   Phase I Studies Pages: 269 - 274

5. Phase I study of idarubicin administered orally on a daily × 3 schedule

   • David J. Stewart
   • Shailendra Verma
   • Betty Fontaine

   Phase I Studies Pages: 275 - 281

6. Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer

   • Elizabeth A. Eisenhauer
   • Kathleen I. Pritchard
   • Joseph L. Pater

   Phase II Studies Pages: 283 - 287

7. Phase II Studies

   • M. John Kennedy
   • Ross C. Donehower
   • Martin D. Abeloff

   OriginalPaper Pages: 289 - 294

8. A phase II study of menogaril (NSC-269148) in colorectal carcinoma

   • Robert P. Whitehead
   • Robert H. Earhart
   • James S. Ungerleider

   Phase II Studies Pages: 295 - 297

9. Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer

   • Jin S. Lee
   • Herman I. Libshitz
   • Waun K. Hong

   Phase II Studies Pages: 299 - 304

10. A phase II study of mitoxantrone in advanced gastric cancer

    • J. A. Levi
    • P. O. Gill
    • P. Presgrave

    Phase II Studies Pages: 305 - 306

11. Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma

    • J. Philip Kuebler
    • Phyllis J. Goodman
    • Julie A. Kish

    Phase II Studies Pages: 307 - 309

12. A phase II trial of echinomycin in metastatic cervix carcinoma

    • T. Hakes
    • M. Markman
    • M. Phillips

    Phase II Studies Pages: 311 - 312

13. Bisantrene in advanced, hormone-resistant carcinoma of the prostate: An Illinois Cancer Council phase II study

    • Nicholas J. Vogelzang
    • Victor J. Lanzotti
    • Richard R. Blough

    Phase II Studies Pages: 313 - 315

14. Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

    • Manuel R. Modiano
    • William S. Dalton
    • Frank L. Meyskens Jr.

    Phase II Studies Pages: 317 - 319

15. Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach

    • David Ginn
    • David Kelsen
    • Gordon Magill

    Phase II Studies Pages: 321 - 324

16. Phase II study of tallysomycin S₁₀b in patients with advanced head and neck cancer

    • Claude Nicaise
    • W. K. Hong
    • I. Krakoff

    Phase II Studies Pages: 325 - 328

17. Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma

    • Howard Hochster
    • Myla Hunt
    • Thomas Smith

    Phase II Studies Pages: 329 - 332

18. Phase II study of esorubicin (4 ′ deoxydoxorubicin) in anthracycline naive patients with ovarian cancer

    • Michael D. Green
    • James L. Speyer
    • E. Mark Beckman

    Phase II Studies Pages: 333 - 336

19. Announcement

    Announcement Pages: 337 - 337